The modern world is the result of innovations developed under a model that no longer works, and companies that want to progress need to employ a new paradigm of open collaboration, reiterated speakers at the well-received SPIE Photonics Innovation Summit on 6 November in the San Francisco-Silicon Valley area.
A new piece of medical technology unveiled at the National Physical Laboratory (NPL) today will help improve the success rates of radiotherapy cancer treatments. The new clinical electron linear accelerator (linac) will help ensure patients are treated with accurate doses of radiation.
Building on the highly popular event that introduces elementary, middle- and high-school students to nanotechnology, more than 300 students received an up-close look at nanobioscience and nanomedicine while attending NanoCareer Day today at the College of Nanoscale Science and Engineering of the University at Albany.
Researchers at the Harvard School of Engineering and Applied Sciences (SEAS) have demonstrated experimentally and theoretically that the surface plasmon resonances of metal nanoparticles in a periodic array can have considerably narrower spectral widths than those of isolated metal nanoparticles.
Scientists have acquired more clues in the mystery of how the spin, or intrinsic angular momentum of a nucleon (proton or neutron), results from its constituent parts, quarks and gluons. Marco Stratmann at RIKEN?s Nishina Center for Accelerator-Based Science in Wako and co-workers have used new scattering data to determine that the contribution from gluons is likely to be small.
A nontoxic nanoparticle developed by researchers at Penn State University is proving to be an all-around effective delivery system for both therapeutic drugs and the fluorescent dyes that can track their delivery.
UT Southwestern Medical Center has received $1.2 million in appropriations from the Department of Defense for 2009. The funding adds to $2 million secured in 2007 and 2008 and will continue collaborative studies with UT Dallas into groundbreaking research projects with the goal of combining nanotechnology and molecular medicine to treat diseases such as cancer and autoimmune-related ailments.
The name has been around for four decades, but only now is a recognisable photonics community emerging in Europe. A European study has documented a fast-growing sector of more than 2100 companies and 700 research laboratories.